Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The field of neurology is continuously seeking innovative solutions for debilitating central nervous system (CNS) disorders. One promising avenue of research involves compounds that can mimic or enhance the activity of neurotrophic factors like Brain-Derived Neurotrophic Factor (BDNF). 7,8-Dihydroxyflavone (7,8-DHF) has emerged as a significant player in this area, acting as a potent TrkB receptor agonist. NINGBO INNO PHARMCHEM CO., LTD., a premier supplier in China, provides this critical research chemical to support advancements in neurological therapeutics.
Understanding 7,8-DHF's Neuroprotective Mechanism
BDNF is essential for the survival, growth, and differentiation of neurons. Its signaling pathway, mediated by the TrkB receptor, is fundamental to maintaining brain health and function. However, BDNF's poor pharmacokinetic profile limits its clinical application. 7,8-Dihydroxyflavone offers an elegant solution by selectively activating the TrkB receptor. This activation triggers the same neurotrophic and neuroprotective downstream signaling cascades as BDNF. Crucially, 7,8-DHF is orally bioavailable and can effectively penetrate the blood-brain barrier, making it a viable candidate for developing treatments for CNS conditions.
Therapeutic Applications in Neurodegenerative Diseases
The research surrounding 7,8-dihydroxyflavone highlights its extensive neuroprotective properties. Studies have demonstrated its efficacy in animal models for a range of neurological disorders, including:
These findings position 7,8-DHF as a pivotal compound in the ongoing search for effective treatments for these challenging conditions. Its ability to act as a BDNF mimetic opens new doors for therapeutic intervention.
Quality and Accessibility from NINGBO INNO PHARMCHEM CO., LTD.
For researchers in the pharmaceutical and biotech industries, securing high-quality chemical intermediates is vital. NINGBO INNO PHARMCHEM CO., LTD. is a trusted manufacturer in China, committed to delivering research-grade 7,8-Dihydroxyflavone. We understand the importance of purity and consistency for successful R&D. If you are looking to buy/purchase this advanced pharmaceutical intermediate, our company ensures reliable supply and adherence to rigorous quality standards, facilitating your journey toward groundbreaking discoveries in neuroprotection.
Investing in the potential of 7,8-DHF is an investment in the future of neurological health. Partner with NINGBO INNO PHARMCHEM CO., LTD. for your research needs and contribute to the advancement of CNS disorder treatments.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
